The Baghiyyatollah al-Azam Military Hospital is a military hospital in Mulla Sadra Street in Vanak, Tehran, Iran. The hospital has ties with the Baqiyatallah University of Medical Sciences.

During the past decade, Baqiatallah Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Baqiatallah Hospital" are "HER2-positive Breast Cancer" (1 trials) and "Malignant Neoplasm of Breast" (1 trials). Many other conditions were trialed in "Baqiatallah Hospital" in a lesser frequency.

Most popular intervention types in "Baqiatallah Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (1 trials), "Docetaxel" (1 trials), "Pertuzumab" (1 trials), "Trastuzumab" (1 trials) and "Trastuzumab plus docetaxel (for four 21-day cycles) after four 14-day cycles of Doxorubicin plus cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baqiatallah Hospital" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Baqiatallah Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Baqiatallah Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Baqiatallah Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".